{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:55:34Z","timestamp":1775732134992,"version":"3.50.1"},"reference-count":93,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nefro Toscana Onlus association"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Paget\u2019s disease of bone (PDB), the second most common bone disease after osteoporosis, is still of unknown etiology and thus deserves attention. PDB and chronic kidney disease (CKD) are chronic diseases characterized by alterations in bone turnover, mineralization, volume, and strength. Both conditions carry an increased cardiovascular risk, as well as increased morbidity and mortality. Both are common in the Western world and primarily affect men over 50 years of age. Despite these similarities, little data exists on their coexistence. Purpose and Methodology: By evaluating the available literature, we found extensive documentation on individual diseases, which has led to consolidated guidelines. The coexistence of the two diseases has provided sporadic studies describing individual cases or small case series. More limited information is available on patients who have received or are eligible for kidney transplants and also have PDB. This narrative (non-systematic) review aims to examine the topic with a particular focus on the relationship between PDB and CKD, especially concerning issues around kidney transplantation. The overlapping factors of the two diseases, and their impact on PDB diagnosis and treatment are discussed. Additionally, examining CKD patients may offer valuable insights for the design of prospective longitudinal or cross-sectional studies aimed at expanding our understanding of PDB. Limitations: The different points of discussion that emerged from the examination of this topic may be useful in the management of PDB-CKD patients but, at the moment, there are not enough data available to draw definitive conclusions to support clinical practice. Conclusions and Future Directions: The coexistence of PDB and CKD is not a rare phenomenon; studying patients with both diseases could provide insights into new research avenues. Above all, and more immediately, attention to the coexistence of the two diseases could improve patient management with personalized choices based on their renal function.<\/jats:p>","DOI":"10.3390\/jcm15082843","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:46:23Z","timestamp":1775727983000},"page":"2843","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paget\u2019s Disease of Bone and Chronic Kidney Disease: A Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Lorena","family":"Traversari","sequence":"first","affiliation":[{"name":"Nephrology and Dialysis Unit, S. Andrea Hospital, Risorgimento Avenue 43, 58024 Massa Marittima, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00068-008-8208-4","article-title":"The second most common bone disease: A review on Paget\u2019s disease of bone","volume":"34","author":"Seitz","year":"2008","journal-title":"Eur. J. Trauma Emerg. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gennari, L., Rendina, D., Merlotti, D., Cavati, G., Mingiano, C., Cosso, R., Materozzi, M., Pirrotta, F., Abate, V., and Calabrese, M. (2022). Update on the pathogenesis and genetics of Paget\u2019s disease of bone. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.932065"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.2002.17.3.465","article-title":"Incidence and natural history of Paget\u2019s disease of bone in England and Wales","volume":"17","author":"Selby","year":"2002","journal-title":"J. Bone Min. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2013.04.024","article-title":"Epidemiology of Paget\u2019s disease of bone: A systemic review and meta-analysis of secular changes","volume":"55","author":"Ralston","year":"2013","journal-title":"Bone"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/jbmr.64","article-title":"Archeological skeletons support a northwest European origin for Paget\u2019s disease of bone","volume":"25","author":"Mays","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_6","unstructured":"Stuart, C., and Fiumicelli, A. (1968). La Osteodistrofia di Paget, Piccinin Editore."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/bmj.285.6347.1005","article-title":"European distribution of Paget\u2019s disease of bone","volume":"285","author":"Detheridge","year":"1982","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1359\/JBMR.050518","article-title":"Prevalence of Paget\u2019s disease of bone in Italy","volume":"20","author":"Gennari","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1359\/jbmr.060822","article-title":"Evidence for Increased Clinical Severity of Familial and Sporadic Paget\u2019s Disease of Bone in Campania, Southern Italy","volume":"21","author":"Rendina","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S8756-3282(99)00027-7","article-title":"Paget\u2019s disease of bone: A review of 889 patients","volume":"24","author":"Davie","year":"1999","journal-title":"Bone"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.5650140203","article-title":"Cell Biology of Paget\u2019s Disease","volume":"14","author":"Reddy","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1172\/JCI24281","article-title":"Paget disease of bone","volume":"115","author":"Roodman","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.abb.2008.02.045","article-title":"Genetics and aetiology of Pagetic disorders of bone","volume":"473","author":"Helfrich","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1302\/0301-620X.63B4.6457839","article-title":"Spinal cord dysfunction in Paget\u2019s disease of bone. Has medical treatment a vascular basis?","volume":"63","author":"Douglas","year":"1981","journal-title":"J. Bone Jt. Surg. Br."},{"key":"ref_15","unstructured":"Siris, E., and Roodman, G.D. (2006). Paget\u2019s Disease of Bone, American Society for Bone and Mineral Research. Chapter 59."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4158\/EP.15.2.158","article-title":"Neurologic complications of Paget disease of Bone","volume":"15","author":"Rubin","year":"2009","journal-title":"Endocr. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1359\/jbmr.1998.13.7.1061","article-title":"Paget\u2019s disease of Bone","volume":"13","author":"Siris","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1359\/jbmr.06s201","article-title":"Update on the Epidemology of Paget\u2019s Disease of Bone","volume":"21","author":"Cooper","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1359\/jbmr.06s211","article-title":"Osteosarcoma in Paget\u2019s disease of bone","volume":"21","author":"Hansen","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jbmr.2349","article-title":"Clinical Characteristics and Evolution of Giant Cell Tumor Occurring in Paget\u2019s Disease of Bone","volume":"30","author":"Rendina","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00186887","article-title":"Metastases of bone affected by Paget\u2019s disease: A report of three cases","volume":"15","author":"Fenton","year":"1991","journal-title":"Int. Orthop."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1359\/JBMR.050322","article-title":"Characteristics and familial aggregation of Paget\u2019s disease of bone in Italy","volume":"20","author":"Merlotti","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12020-018-1771-5","article-title":"Increased frequency of impaired fasting glucose and isolated systolic hypertension in Paget\u2019s disease of bone","volume":"63","author":"Barale","year":"2019","journal-title":"Endocrine"},{"key":"ref_24","first-page":"360","article-title":"Frequency of Metabolic Syndrome in Paget\u2019s Disease of Bone","volume":"56","author":"Erol","year":"2022","journal-title":"Med. Bull. Sisli Etfal Hosp."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e4430","DOI":"10.1210\/clinem\/dgaa576","article-title":"Increased Prevalence of Nephrolithiasis and Hyperoxaluria in Disease of Bone","volume":"105","author":"Rendina","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0049-0172(94)90037-X","article-title":"Epidemiological aspects of Paget\u2019s disease: Family history and relationship to other medical conditions","volume":"23","author":"Siris","year":"1994","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_27","first-page":"99","article-title":"Parathyroid function in Paget\u2019s disease of bone","volume":"49","author":"Chapuy","year":"1982","journal-title":"Rev. Rhum. Mal. Osteoartic."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jbmr.5650040111","article-title":"Parathyroid function in Paget\u2019s disease of bone","volume":"4","author":"Siris","year":"1989","journal-title":"J. Bone Miner. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/art.1780231005","article-title":"Bone histomorphometry in Paget\u2019s disease","volume":"23","author":"Meunier","year":"1980","journal-title":"Arthritis Rheum."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"P69","DOI":"10.1359\/jbmr.06s213","article-title":"What is the realtionship between Paget\u2019s disease of bone and Hyperparothyroidism?","volume":"21","author":"Brandi","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/art.1780231016","article-title":"Long-term therapy of Paget\u2019s disease of bone with EHDP","volume":"23","author":"Siris","year":"1980","journal-title":"Arthritis Rheum. Off. J. Am. Coll. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-54-4-837","article-title":"Long-term effects of dichloromethylene diphosphonate in Paget\u2019s disease of bone","volume":"54","author":"Delmas","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(79)91318-7","article-title":"Treatment of Paget\u2019s disease with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (A.P.D.)","volume":"1","author":"Frijlink","year":"1979","journal-title":"Lancet"},{"key":"ref_34","first-page":"S400","article-title":"Prolunged hypocalcemia from intravenous zolendronic acid: An unusual case","volume":"20","author":"Talwar","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jbmr.3657","article-title":"Diagnosis and Management of Paget\u2019s Disease of Bone in Adults: A Clinical Guideline","volume":"34","author":"Ralston","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0002-9343(96)00227-6","article-title":"Biochemical and radiologic improvement in Paget\u2019s disease of bone treated with alendronate: A randomized, placebo-controlled trial","volume":"101","author":"Reid","year":"1996","journal-title":"Am. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1359\/jbmr.090709","article-title":"Randomized trial of intensive bisphosphonate treatment versus syntomatic management in Paget\u2019s disease of bone","volume":"25","author":"Langston","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00223-012-9652-z","article-title":"Implications of a new radiological approach for the assessment of Paget\u2019s disease","volume":"91","author":"Guanabens","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"ref_39","first-page":"523","article-title":"Bone scanning in evalutation of Paget\u2019s disease of bone","volume":"5","author":"Shirazi","year":"1974","journal-title":"CRC Crit. Rev. Clin. Radiol. Nucl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1148\/radiology.173.2.2798865","article-title":"Paget\u2019s disease: MR imaging findings","volume":"173","author":"Roberts","year":"1989","journal-title":"Radiology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1359\/jbmr.2004.19.4.566","article-title":"Paget\u2019s disease of bone in the Netherlands: A population-based radiological and biochemical survey-the Rotterdam Study","volume":"19","author":"Eekhoff","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jbmr.5650100318","article-title":"Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget\u2019s disease","volume":"10","author":"Alvarez","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00198-015-3095-0","article-title":"Bone turnover markers in Paget\u2019s disease of the bone: A Systematic review and meta-analysis","volume":"26","author":"Altayar","year":"2015","journal-title":"Osteoporos. Int."},{"key":"ref_44","first-page":"CD004956","article-title":"Bisphosphonates for Paget\u2019s disease of bone in adults","volume":"12","author":"Tan","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_45","unstructured":"(2026, March 26). Agenzia Italiana del Farmaco. Available online: https:\/\/www.teriparatide,farmaci-agenzia farmaco.it."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e10665","DOI":"10.1002\/jbm4.10665","article-title":"Teriparatide and Osteosarcoma Risk: History, Science, Elimination of Boxed Warning, and Other Label Updates","volume":"6","author":"Krege","year":"2022","journal-title":"JBMR Plus"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10354-016-0502-x","article-title":"Diagnosis and treatment of Paget\u2019s disease of bone: A clinical practice guideline","volume":"167","author":"Muschitz","year":"2017","journal-title":"Wien. Med. Wochenschr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1210\/jc.2014-2910","article-title":"Paget\u2019s disease of bone: An Endocrine Society clinical practice guideline","volume":"99","author":"Singer","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_49","first-page":"224","article-title":"Paget\u2019s Disease of Bone for Primary Care","volume":"102","author":"Nahid","year":"2020","journal-title":"Am. Fam. Physician"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3399\/bjgp20X713369","article-title":"Paget\u2019s disease of bone: When and why to refer to specialist care","volume":"70","author":"Nairn","year":"2020","journal-title":"Br. J. Gen. Pract."},{"key":"ref_51","first-page":"207","article-title":"Paget\u2019s disease of bone: 1877\u20132023. Etiology and management of a disease on epidemiological transition","volume":"161","author":"Gudino","year":"2023","journal-title":"Med. Clin."},{"key":"ref_52","unstructured":"(2026, March 26). ISTAT (Istituto Nazionale di Statistica). Available online: https:\/\/www.demo.istat.it."},{"key":"ref_53","first-page":"542","article-title":"Enfermedad de Paget poliostotica asintomatica asociada a hiperparatiroidismo secundario en dialisis peritonea","volume":"32","year":"2012","journal-title":"Nefrologia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2008-1068837","article-title":"Unusual course of renal osteopathy with Paget\u2019s Disease and alluminum deposit","volume":"110","author":"Ringe","year":"1985","journal-title":"Dtsch. Med. Wochenschr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/ndt\/13.9.2394","article-title":"The dialysis patient with persisting elevation of bone alkaline phosphatase after parathyroidectomy","volume":"13","author":"Lorho","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_56","first-page":"105","article-title":"Paget\u2019s Disease of Bone in a Patient on Hemodialysis","volume":"2","author":"Estremadi","year":"2008","journal-title":"Iran. J. Kydney Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1726-4901(09)70022-X","article-title":"Monostotic Vertebral Paget\u2019s Disease of the Lumbar Spine","volume":"72","author":"Wu","year":"2009","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5414\/CNP73403","article-title":"A case of Paget\u2019s disease in hemodialysis","volume":"73","author":"Cianciolo","year":"2010","journal-title":"Clin. Neprol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2324709616640818","DOI":"10.1177\/2324709616640818","article-title":"Transient Hypocalcemia in a Dialysis Patient with Paget\u2019s diesease and Presumed Renal Cell carcinoma","volume":"4","author":"Kenneth","year":"2016","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_60","first-page":"528","article-title":"Effective Treatment of Paget\u2019s Disease of the Bone in a Chinese Woman","volume":"47","author":"Kuthiah","year":"2018","journal-title":"Ann. Acad. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e17458","DOI":"10.1097\/MD.0000000000017458","article-title":"Paget disease of Bone in an ederly patient with chronic renal disease and weight loss. A case report","volume":"98","author":"Chan","year":"2019","journal-title":"Medicine"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Panuccio, V.A., and Tripepi, R. (2020). Paget\u2019s Disease and Secondary Hyperparathytoidism: Is Healing Possible?. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00399"},{"key":"ref_63","first-page":"110","article-title":"Denosumab Experience in a Patient with End-Stage Renal Disease and Paget\u2019s Disease of the Bone","volume":"30","author":"Elbuken","year":"2022","journal-title":"Turk. Klin. J. Case Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.eprac.2025.05.424","article-title":"A Case of Paget\u2019s Disease of Bone in a Patient on Hemodialysis","volume":"31","author":"Hand","year":"2025","journal-title":"Endocr. Pract."},{"key":"ref_65","first-page":"2496","article-title":"Paget\u2019s Disease of Bone and Chronic Kidney Disease: Three Case Reports","volume":"10","author":"Traversari","year":"2025","journal-title":"Ann. Case Rep."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Yavuz, D.G., and Salva, H. (2026). The Overlooked bone Disease: Paget\u2019s in a chronic kidney disease\u2014Mineral and bone disorder context. JCEM Case Rep., 4.","DOI":"10.1210\/jcemcr\/luaf297.022"},{"key":"ref_67","first-page":"319","article-title":"Manifestations ost\u00e9o-articulaires du dialys\u00e9 de plus de 70 ans","volume":"11","author":"Kessler","year":"1990","journal-title":"Nephrologie"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ki.2012.69","article-title":"Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease","volume":"82","author":"Torres","year":"2012","journal-title":"Kidney Int."},{"key":"ref_69","unstructured":"KDIGO (2013). Management Guideline, Chapter 3: Management of progression and complications of CKD. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease; Kidney International Supplements, Elsevier."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: Key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/sdi.12388","article-title":"Pharmacology of Bisphosphonates in Patients with Chronic Kidney Disease","volume":"28","author":"Ott","year":"2015","journal-title":"Semin. Dial."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bone.2010.12.024","article-title":"The kidney and bisphosphonates","volume":"49","author":"Miller","year":"2011","journal-title":"Bone"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"837573","DOI":"10.1155\/2013\/837573","article-title":"Bisphosphonates in CKD Patients with Low Bone Mineral Density","volume":"2013","author":"Liu","year":"2013","journal-title":"Sci. World J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1111\/bcp.14780","article-title":"Bisphosphonates nephropathy: A case series and review of the literature","volume":"87","author":"Floquin","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.356","article-title":"Bisphosphonates nephrotoxicity","volume":"74","author":"Perazella","year":"2008","journal-title":"Kidney Int."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s11606-010-1316-y","article-title":"Diagnosis and Management of Mineral Metabolism in CKD","volume":"25","author":"Bhan","year":"2010","journal-title":"J. Gen. Intern. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"450","DOI":"10.5301\/jn.5000188","article-title":"Bisphosphonate therapy in renal ostreodystrophy\u2014A review","volume":"26","author":"Bergner","year":"2013","journal-title":"J. Nephrol."},{"key":"ref_78","unstructured":"KDIGO (2017). KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD), Elsevier. Available online: www.kisupplements.org."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1053\/j.ajkd.2020.03.023","article-title":"NSAIDs in CKD: Are They Safe?","volume":"76","author":"Baker","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nefro.2015.05.021","article-title":"Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: \u201cThe Triple Whammy\u201d","volume":"3","author":"Camin","year":"2015","journal-title":"Nefrologia"},{"key":"ref_81","unstructured":"Sessa, C., Goleano, D., Alessandello, I., Aprile, G., Distefano, G., Ficara, V., Giglio, E., Musumeci, S., Pocorobba, B., and Zuppardo, C. (2019). Osteoporosi e malattia renale cronica: Vecchie e nuove strategie terapeutiche allo stato dell\u2019arte. Osteoporosis and chronic kidney disease: Review and new therapeutic strategies. G. Ital. Nefrol., 36."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Bellorin-Font, E., Rojas, E., and Martin, K.J. (2023). Bone Disease in Chronic Kidney Disease and Kydney Transplant. Nutrients, 15.","DOI":"10.3390\/nu15010167"},{"key":"ref_84","first-page":"S3","article-title":"Introduction and definition of CKD-MBD and the development of the guideline statement","volume":"79","author":"Guideline","year":"2009","journal-title":"Kidney Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/TP.0000000000003137","article-title":"Summary of the kidney disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Jedrzejuk, D., Poznanski, P., Szewczyk, P., Mazanowska, O., Bolanowski, M., Krajewska, M., and Kami\u0144ska, D. (2023). Newly Diagnosed Monostotic Paget\u2019s Disease of Bone during Living Kidney Donor Candidate Evaluation. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020401"},{"key":"ref_87","unstructured":"Gregorini, M., Pattonieri, E.F., Fasoli, G., Valente, M., La Porta, E., Canevari, M., Erasmi, F., and Rampino, T. (2017). La selezione del donatore e del ricevente nel trapianto di rene da donatore vivente: Iter di idoneit\u00e0. G. Ital. Nefrol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"237","DOI":"10.33393\/gcnd.2018.603","article-title":"Il trapianto renale da cadavere: Valutazione di idoneit\u00e0 del donatore e del rene","volume":"30","author":"Tsalouchos","year":"2018","journal-title":"G. Tec. Nefrol. Dial."},{"key":"ref_89","first-page":"325","article-title":"L\u2019assistenza a lungo termine del paziente trapiantato di rene","volume":"25","author":"Icardi","year":"2008","journal-title":"G. Ital. Nefrol."},{"key":"ref_90","first-page":"144","article-title":"Il rischio cardiovascolare nel paziente con trapianto renale","volume":"2","author":"Stallone","year":"2004","journal-title":"G. Ital. Nefrol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s40618-024-02318-1","article-title":"Diagnosis and treatment of Paget\u2019s disease of bone: Position paper from the Italian Society of osteoporosis, Mineral Metabolism and Skeletal Disease (SIOMMMS)","volume":"47","author":"Rendina","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Sintesi delle Linee guida di pratica clinica KDIGO 2024 per la valutazione e la gestione lella malattia renale cronica: Conoscenze acquisite e incognite note","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int."},{"key":"ref_93","unstructured":"(2026, March 26). Available online: https:\/\/www.osservatriomalattierare.it."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/2843\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:59:33Z","timestamp":1775728773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/2843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":93,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["jcm15082843"],"URL":"https:\/\/doi.org\/10.3390\/jcm15082843","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}